• Empower your cancer research with proteomics

    Scalable and validated platform for biomarker discovery

    Protein biomarkers are increasingly emerging as actionable “liquid biopsies” to better understand cancer biology, identify risk factors, stratify patient populations, provide diagnostic, prognostic and therapeutic response markers and to drive development of new, more effective therapies. Olink’s scalable, validated platform for exceptional quality, multiplexed protein biomarker discovery and development is making an increasing impact in several key areas of cancer research.

    Did you know?

    Olink’s Proximity Extension Assay (PEA) technology
    for protein biomarker discovery has been cited in
    over 160 peer-reviewed publications in the fields of
    oncology and cancer immunotherapy.

    Read Olink publications

    Join our AACR 2023 Exhibitor Spotlight

    Sunday, April 16th

    3:30 – 4:30 EDT

    Theater C

    “Development of plasma proteomic biomarkers in patients with melanoma and gastroesophageal cancer”

    Please join us Sunday, April 16th, from 3:30 – 4:30 EDT in Exhibitor Spotlight Theater C for this exciting seminar given by Ryan Sullivan, MD and Genevieve Boland, M, MD, PhD. In this session, learn how these researchers developed an approach using Olink’s PEA platform to identify novel proteomic markers of resistant and immunogenic phenotypes of the tumor microenvironment.

     

    Speakers

    MicrosoftTeams-image (11)

    Ryan Sullivan, MD
    Associate Director, Melanoma Program Mass General Cancer Center; Associate Professor, Harvard Medical School

    Russell-W.-Jenkins,-MD,-PhD

    Russell W. Jenkins, MD, PhD,
    Assistant Professor, Harvard Medical School; Faculty Member, Center for Cancer Research; Associate Member, Broad Institute of MIT and Harvard

    A benchtop system for protein biomarker analysis

    Olink® Signature Q100

    Olink Signature Q100 is a user-friendly instrument for readout of all Olink® Flex, Target and Focus protein biomarker panels. Olink Flex, combined with Olink Signature Q100, gives you an efficient workflow with robust performance. There is no need for time-consuming washing steps that could cause loss of material. Learn more about this benchtop solution and how to streamline your protein biomarker analysis.

    Demo the Signature Q100 at our booth

    Flexibility without compromise

    Introducing Olink® Flex

    Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel

    Learn more about Olink Flex

    2947

    Biomarker assays

    ~881 million

    Protein data points generated

    1281

    Publications listed on website

    Contact us!